These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34587166)
1. Anti-inflammatory activity of lefamulin versus azithromycin and dexamethasone in vivo and in vitro in a lipopolysaccharide-induced lung neutrophilia mouse model. Hafner M; Paukner S; Wicha WW; Hrvačić B; Cedilak M; Faraho I; Gelone SP PLoS One; 2021; 16(9):e0237659. PubMed ID: 34587166 [TBL] [Abstract][Full Text] [Related]
2. In Vivo Immune-Modulatory Activity of Lefamulin in an Influenza Virus A (H1N1) Infection Model in Mice. Paukner S; Kimber S; Cumper C; Rea-Davies T; Sueiro Ballesteros L; Kirkham C; Hargreaves A; Gelone SP; Richards C; Wicha WW Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791439 [TBL] [Abstract][Full Text] [Related]
3. Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1beta. Bosnar M; Bosnjak B; Cuzic S; Hrvacic B; Marjanovic N; Glojnaric I; Culic O; Parnham MJ; Erakovic Haber V J Pharmacol Exp Ther; 2009 Oct; 331(1):104-13. PubMed ID: 19633061 [TBL] [Abstract][Full Text] [Related]
4. Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia. Zhanel GG; Deng C; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Berry L; Schweizer F; Zhanel MA; Irfan N; Bay D; Lagacé-Wiens P; Walkty A; Mandell L; Lynch JP; Karlowsky JA Drugs; 2021 Feb; 81(2):233-256. PubMed ID: 33247830 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics/pharmacodynamics of lefamulin in a neutropenic murine pneumonia model with Staphylococcus aureus and Streptococcus pneumoniae. Wicha WW; Strickmann DB; Paukner S J Antimicrob Chemother; 2019 Apr; 74(Suppl 3):iii11-iii18. PubMed ID: 30949707 [TBL] [Abstract][Full Text] [Related]
6. Low intensity laser therapy (LILT) in vivo acts on the neutrophils recruitment and chemokines/cytokines levels in a model of acute pulmonary inflammation induced by aerosol of lipopolysaccharide from Escherichia coli in rat. Mafra de Lima F; Villaverde AB; Salgado MA; Castro-Faria-Neto HC; Munin E; Albertini R; Aimbire F J Photochem Photobiol B; 2010 Dec; 101(3):271-8. PubMed ID: 20728373 [TBL] [Abstract][Full Text] [Related]
7. Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia. Bosnar M; Čužić S; Bošnjak B; Nujić K; Ergović G; Marjanović N; Pašalić I; Hrvačić B; Polančec D; Glojnarić I; Eraković Haber V Int Immunopharmacol; 2011 Apr; 11(4):424-34. PubMed ID: 21195124 [TBL] [Abstract][Full Text] [Related]
8. Safety and Pharmacokinetics Following Oral or Intravenous Lefamulin in Adults With Cystic Fibrosis. Sawicki GS; Wicha WW; Hiley TS; Close NC; Gelone SP; Guico-Pabia CJ Clin Ther; 2024 Feb; 46(2):96-103. PubMed ID: 38195348 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of PAF-, LPS-, and cytokine-induced granulocyte accumulation in guinea pig lung by dexamethasone: evidence that inhibition of IL-5 release is responsible for the selective inhibition of eosinophilia by glucocorticoids in guinea-pigs. Whelan CJ Inflamm Res; 1996 Apr; 45(4):166-70. PubMed ID: 8741005 [TBL] [Abstract][Full Text] [Related]
13. Differential anti-inflammatory and anti-oxidative effects of dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation. Rocksén D; Lilliehöök B; Larsson R; Johansson T; Bucht A Clin Exp Immunol; 2000 Nov; 122(2):249-56. PubMed ID: 11091282 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial. File TM; Goldberg L; Das A; Sweeney C; Saviski J; Gelone SP; Seltzer E; Paukner S; Wicha WW; Talbot GH; Gasink LB Clin Infect Dis; 2019 Nov; 69(11):1856-1867. PubMed ID: 30722059 [TBL] [Abstract][Full Text] [Related]
15. Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia. Tang HJ; Wang JH; Lai CC Medicine (Baltimore); 2020 Jul; 99(29):e21223. PubMed ID: 32702892 [TBL] [Abstract][Full Text] [Related]
17. Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities. File TM; Alexander E; Goldberg L; Das AF; Sandrock C; Paukner S; Moran GJ BMC Pulm Med; 2021 May; 21(1):154. PubMed ID: 33964925 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of flavonoids extracted from licorice on lipopolysaccharide-induced acute pulmonary inflammation in mice. Xie YC; Dong XW; Wu XM; Yan XF; Xie QM Int Immunopharmacol; 2009 Feb; 9(2):194-200. PubMed ID: 19071231 [TBL] [Abstract][Full Text] [Related]
19. A Review of Newly Approved Antibiotic Treatment for Community-Acquired Bacterial Pneumonia: Lefamulin. Wang H; Charles CV Sr Care Pharm; 2020 Aug; 35(8):349-354. PubMed ID: 32718391 [TBL] [Abstract][Full Text] [Related]